FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 360:1526-1538 April 9, 2009 Number 15 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text PowerPoint Slide Set CME Exam Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

Myocarditis may present with a wide range of symptoms, ranging from mild dyspnea or chest pain that resolves without specific therapy to cardiogenic shock and death. Dilated cardiomyopathy with chronic heart failure is the major long-term sequela of myocarditis. Most often, myocarditis results from common viral infections; less commonly, specific forms of myocarditis may result from other pathogens, toxic or hypersensitivity drug reactions, giant-cell myocarditis, or sarcoidosis. The prognosis and treatment of myocarditis vary according to the cause, and clinical and hemodynamic data usually provide guidance to decide when to refer a patient to a specialist for endomyocardial biopsy. The . . . [Full Text of this Article]

Definition

Clinical Manifestations and Incidence

Causative Agents

Pathogenetic Features

Diagnosis

Treatment

Summary and Future Directions

Source Information

From the Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.

Address reprint requests to Dr. Cooper at the Division of Cardiovascular Diseases, Mayo Clinic, 200 First St. SW, Rochester, MN 55905, or at cooper.leslie@mayo.edu.

Related Letters:

Myocarditis
Kapoor J. R., Szabo S., Oikonomopoulos T., Hoffmeister H. M., Ammar H., Fouda R., Cooper L. T. Jr.
Extract | Full Text | PDF  
N Engl J Med 2009; 361:422-424, Jul 23, 2009. Correspondence

This article has been cited by other articles:

• Blyszczuk, P., Kania, G., Dieterle, T., Marty, R. R., Valaperti, A., Berthonneche, C., Pedrazzini, T., Berger, C. T., Dirnhofer, S., Matter, C. M., Penninger, J. M., Luscher, T. F., Eriksson, U. (2009). Myeloid Differentiation Factor-88/Interleukin-1 Signaling Controls Cardiac Fibrosis and Heart Failure Progression in Inflammatory Dilated Cardiomyopathy. Circ. Res. 105: 912-920 [Abstract] [Full Text]  
• Cunningham, M. W. (2009). Turning Point in Myocarditis. Circ. Res. 105: 403-405 [Full Text]  
• Luo, H., Wong, J., Wong, B. (2009). Protein degradation systems in viral myocarditis leading to dilated cardiomyopathy. Cardiovasc Res 0: cvp225v2-cvp225 [Abstract] [Full Text]  
• Cooper, L. T. (2009). The heat is off: immunosuppression for myocarditis revisited. Eur Heart J 30: 1936-1939 [Full Text]  
• Kapoor, J. R., Szabo, S., Oikonomopoulos, T., Hoffmeister, H. M., Ammar, H., Fouda, R., Cooper, L. T. Jr. (2009). Myocarditis. NEJM 361: 422-424 [Full Text]